|Commenter:||Mrs. Phyllis Yasuda|
|Agency:||Federal Trade Commission|
|Rule:||16 CFR Part 425: "Rule Concerning the Use of Prenotification Negative Option Plans"|
Comments:Please do what you can to prevent misleading advertising, especially "free trials" in the medical arena which do not end at the end of the period and for which the customer is thereafter charged at higher than expected rates. These customers are most often those feeling vulnerable because of age or illness and are, therefore, easy prey to unscrupulous vendors. There are many honorable businesses that suffer unfairly as a result of the actions of these few advertisers.